Read more here
GenOway is a French biotechnology company headquartered in Lyon, specializing in predictive preclinical solutions to help its customers select the most effective and safest drug candidates. Founded in 1999, GenOway operates in over 28 countries.
Our partners Denis Santy and Huini Li advised and supported Genoway in its discussions and the establishment of its joint venture in Shanghai, China. The recently concluded final agreement underlines the shareholders’ determination to pursue joint commercial success in the fast-growing Chinese market: “Our ambition through this joint venture is to become the market leader in China for innovative preclinical immuno-oncology solutions by 2027”, says the CFO.